HIGHLIGHTS
- who: . et al. from the Camilo Josu00e9 Cela University, Spain have published the Article: Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases, in the Journal: (JOURNAL)
- how: The authors conducted this study in accordance with the current Declaration of Helsinki.
SUMMARY
Pharmacokinetic pDDIs affect the liberation, absorption, distribution, metabolism and elimination of drugs, e_g, through the inhibition or induction of metabolic enzymes like the cytochrome P450 (CYP) isozymes or through reduced absorption due to complexation of active substances (Koziolek et_al, 2019 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.